Author:
Averna M. A.,Stanzial A.,Bonafanti F.,di Fede G.,Montalto G.,Muggeo M.,Notarbartolo A.
Reference8 articles.
1. Klose G., Mordasini R., Middelhoff G., Augustin J. and Gruten H. (1978). Medikamentose Behandlung Primarer Hyper-lipoproteinamien. Klin. Wschr., 56, 99.
2. Berge K.G., Achor R.W.P., Christensen N.A, Mason H.L. and Barker N.W. (1961). Hypercholesterolemia and Nicotinic Acid. A long-term study. Am. J. Med., 31, 24.
3. Carlson L.A., Oro L. and Ostman J. (1968). Effect of Nicotinic Acid on Plasma Lipids in Patients with Hyperlipoproteinemia During the First Week of Treatment. J. Atheroscler. Res., 8, 667.
4. Fuccella L.M., Goldaniga G., Lovisolo P.P., Maggi E., Musatti L., Mandelli V. and Sirtori C.R. (1980). Inhibition of Lipolysis by Nicotinic Acid and by Acipimox. Clin. Pharmacol. Ther., 28, 790.
5. Micheli H., Pometta D. and Gustafson A. (1979). Treatment of Hyperlipoproteinemia (HLP) Type IIA with a New Phenoxyisobutiric Acid Derivative. Procetofen. Intern. J. Clin. Pharmacol. and Bioph., 17, 503.